Millions of people with Medicare will soon be eligible to get discounted GLP-1 drugs for weight loss. Here's how it will work ...
The Centers for Medicare and Medicaid Services’ Medicare GLP-1 Bridge program will decrease certain GLP-1 costs, which local ...
The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with some downsides takes its place.
The proposed rule aims to improve prior authorization for prescription drugs by establishing and requiring electronic prior ...
Leading Republicans are looking toward the Government Accountability Office (GAO) to ensure CMS' new premium stabilization demonstration program is legal and in the best interest of seniors. In a ...
The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare.
On April 23, 2026, the Food and Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS) jointly announced the ...
CMS has published a list of 202 measures under consideration for use in hospitals and other Medicare public reporting and payment programs. In publishing the list, CMS will be able to gain input on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results